Pasar al contenido principal

FACTORES GENETICOS MODIFICADORES EXPLICATIVOS DE PENETRANCIA INCOMPLETA Y EXPRESIVIDAD VARIABLE EN FIEBRES PERIODICAS

PID2021-125106OB-C32

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Somatic reversion in CD137 deficiency correlating with Epstein-Barr virus control and clinical improvement

  • Batlle-Masó, Laura|||0000-0002-4209-176X
  • Padrosa Pulido, Joan|||0000-0002-3354-5811
  • Esteve-Codina, Anna|||0000-0003-0361-2873
  • Perurena-Prieto, Janire
  • Franco-Jarava, Clara|||0000-0002-9788-189X
  • Aguiló-Cucurull, Aina|||0000-0001-5622-778X
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Cea López, Cristina|||0000-0003-0776-6706
  • Rodriguez-Aliberas, Marta
  • Soler Palacín, Pere|||0000-0002-0346-5570
  • Casals, Ferran|||0000-0002-8941-0369
  • Redondo, Sara|||0000-0001-8967-7410
  • Torrent, Montserrat|||0000-0003-1917-1056
  • Alsina Manrique, Laia|||0000-0002-3559-0018
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
Epstein-Barr virus (EBV) is an oncogenic virus ubiquitous in human populations. CD8 T cells play a crucial role in establishing a strong anti-EBV immune response. Among the various inborn errors of immunity (IEI) showing a restricted vulnerability to EBV, TNFRSF9 (CD137, 4-1BB) deficiency was described in 2019 in patients with chronic EBV viremia and EBV-associated lymphoproliferative diseases. We here investigated a patient with a history of chronic EBV infection and CD137 deficiency who had previously undergone transplantation from her HLA-identical brother. We found that the brother was also a homozygous carrier of the same TNFRSF9 variant, explaining the patient's inability to control EBV after transplantation. Remarkably, during a period of spontaneous clinical improvement and EBV control, we detected two somatic variants in the patient, which resulted in the emergence of two independent revertant CD8 T cell clones that accounted for up to 20% of CD8 T cells in peripheral blood. Using single cell RNA sequencing we demonstrated that both revertant clones originated post-transplant from donor-derived cells. We report here the first described case of a somatic reversion phenomenon in TNFRSF9 deficiency, correlating with clinical improvement and paving the way for future gene therapy strategies for this IEI.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Novel insights into the clinical features, genetic spectrum and clonal evolution of patients carrying NLRP3 mosaicism

  • Bonet, Núria
  • Pesqué, David
  • Giménez Arnau, Anna Maria
  • Laayouni, Hafid, 1968-
  • Fornas Carreño, Oscar
  • Aróstegui Gorospe, Juan Ignacio
NLRP3 mosaicism is a well-established mechanism causing the monogenic autoinflammatory disease named cryopyrin-associated periodic syndromes (CAPS). The number of reported patients with NLRP3 mosaicism is small, and the knowledge about the long-term disease behavior is limited. Herein we assembled the largest cohort of individuals with NLRP3 mosaicism reported to date to obtain additional evidence that strengthens the understanding of this disease. The novel genetic data were obtained by using Sanger and next-generation sequencing methods, whereas in vitro analyses determined the functional consequences of detected variants. A total of seventeen individuals with NLRP3 mosaicism were enrolled, with 16/17 experiencing different CAPS phenotypes. An overrepresentation of late-onset forms was detected (37.5%). Overall, clinical manifestations, analytical results, and outcomes of treatments were markedly similar to those detected in patients with germline variants. A large mutational diversity was identified, with 16 different variants among 17 individuals. Two main patterns of mosaicism (extended vs. myeloid-restricted) were detected, with the last one overrepresented in the late-onset group. The evaluation of mosaicism over time identified three different patterns, being the group with stable mosaicism the largest one. Collected evidence supports the marked similarities among patients carrying somatic or germline NLRP3 variants. The overrepresentation of NLRP3 mosaicism in late-onset forms should be considered in patients with inflammatory manifestations starting in adulthood. Analysis of mosaicism at the biological level confirms the two known patterns of corporal distribution and reveals that mosaicism remains stable over time in most patients, but it may also vary during the course of the disease., This work has been partially funded by: • PID2021-125106OB-C31 (JIA), PID2020-116709RB-I00 (PP), CNS2022-135101 (PP), PID2023-147531OB-I00 (PP), PID2021-125106OB-C32 (FC), RED2022-134511-T (PP, JIA) and PID2021-125106OB-C33 (OF) grants from the Ministerio de Ciencia e Innovación (MCIN) | Agencia Estatal de Investigación (AEI) | https://doi.org/10.13039/501100011033 | Fondo Europeo de Desarrollo Regional (FEDER), UE | European Union «Next Generation EU/PRTR». • AC21_2/00042 (JIA) and IFI22/00031 (JG-V) grants from the Instituto de Salud Carlos III co-funded by Unión Europea Next Generation EU | Mecanismo para la Recuperación y la Resiliencia (MRR) | Plan de Recuperación, Transformación y Resiliencia (PRTR). • 2021SGR01093 | Agència de Gestió d’Ajuts Universitaris i de Recerca | Generalitat de Catalunya (FC). • 21897/PI/22 (PP) and 21214/FPI/19 (LH-N) | Fundación Séneca, Región de Murcia, Spain.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism

  • Mascaró, Jose Manuel
  • Tejedor Vaquero, Sonia, 1988-
  • Magri, Giuliana, 1978-
  • Bonet, Núria
  • Solís Moruno, Manuel, 1993-
  • Cerutti, Andrea, 1965-
  • Fornas Carreño, Oscar
  • Aróstegui Gorospe, Juan Ignacio
Background: The vacuoles, E1-enzyme, X linked, autoinflammatory and somatic (VEXAS) syndrome is an adult-onset autoinflammatory disease (AID) due to postzygotic UBA1 variants. Objectives: To investigate the presence of VEXAS syndrome among patients with adult-onset undiagnosed AID. Additional studies evaluated the mosaicism distribution and the circulating cytokines. Methods: Gene analyses were performed by both Sanger and amplicon-based deep sequencing. Patients' data were collected from their medical charts. Cytokines were quantified by Luminex. Results: Genetic analyses of enrolled patients (n=42) identified 30 patients carrying UBA1 pathogenic variants, with frequencies compatible for postzygotic variants. All patients were male individuals who presented with a late-onset disease (mean 67.5 years; median 67.0 years) characterised by cutaneous lesions (90%), fever (66.7%), pulmonary manifestations (66.7%) and arthritis (53.3%). Macrocytic anaemia and increased erythrocyte sedimentation rate and ferritin were the most relevant analytical abnormalities. Glucocorticoids ameliorated the inflammatory manifestations, but most patients became glucocorticoid-dependent. Positive responses were obtained when targeting the haematopoietic component of the disease with either decitabine or allogeneic haematopoietic stem cell transplantation. Additional analyses detected the UBA1 variants in both haematopoietic and non-haematopoietic tissues. Finally, analysis of circulating cytokines did not identify inflammatory mediators of the disease. Conclusion: Thirty patients with adult-onset AID were definitively diagnosed with VEXAS syndrome through genetic analyses. Despite minor interindividual differences, their main characteristics were in concordance with previous reports. We detected for the first time the UBA1 mosaicism in non-haematopoietic tissue, which questions the previous concept of myeloid-restricted mosaicism and may have conceptual consequences for the disease mechanisms., This work has been partially funded by RTI2018-096824-B-C21 (JIA) and RTI2018-096824-B-C22 (FC) grant from the Spanish Ministry of Science, Innovation and Universities co-funded by Agencia Estatal de Investigación/European Regional Development Fund una manera de hacer Europa. PID2021-125106OB-C31 (JIA) and PID2021-125106OB-C32 (FC) grants from the Ministerio de Ciencia e Innovación (MCIN) | Agencia Estatal de Investigación (AEI) | 10.13039/501100011033 | Fondo Europeo de Desarrollo Regional (FEDER), UE.PI19/01567 grant from Instituto de Salud Carlos III (ISCIII) co-funded by the European Union (AM-V).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Somatic genetic variation in healthy tissue and non-cancer diseases

  • Solís Moruno, Manuel, 1993-
  • Batlle Masó, Laura, 1993-
  • Bonet, Núria
  • Aróstegui Gorospe, Juan Ignacio
  • Casals López, Ferran
Somatic genetic variants have been studied for several years mostly concerning cancer, where they contribute to its origin and development. It is also clear that the somatic variants load is greater in aged individuals in comparison to younger ones, pointing to a cause/consequence of the senescence process. More recently, researchers have focused on the role of this type of variation in healthy tissue and its dynamics in cell lineages and different organs. In addition, somatic variants have been described to contribute to monogenic diseases, and the number of evidences of their role in complex disorders is also increasing. Thanks to recent advances in next-generation sequencing technologies, this type of genetic variation can be now more easily studied than in the past, although we still face some important limitations. Novel strategies for sampling, sequencing and filtering are being investigated to detect these variants, although validating them with an orthogonal approach will most likely still be needed. In this review, we aim to update our knowledge of somatic variation detection and its relation to healthy tissue and non-cancer diseases., This study was funded by grants PID2021-125106OB-C32 (FC), RTI2018-096824-B-C22 (FC), RTI2018-096824-B-C21 (JIA) and PID2021-125106OB-C31 (JIA) funded by MCIN/ AEI /10.13039/501100011033/ and FEDER Una manera de hacer Europa; Direcció General de Recerca- Generalitat de Catalunya (2017SGR-702) (FC); and CERCA Programme/Generalitat de Catalunya (JIA). MS-M was supported by the Ministerio de Economía y Competitividad, Spain (Maria de Maetzu grant MDM-2014-0370-16-3).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Assessing the digenic model in rare disorders using population sequencing data

  • Moreno-Ruiz, Nerea
  • Genomics England Research Consortium
  • Lao Grueso, Oscar, 1976-
  • Aróstegui Gorospe, Juan Ignacio
  • Laayouni, Hafid, 1968-
  • Casals López, Ferran
An important fraction of patients with rare disorders remains with no clear genetic diagnostic, even after whole-exome or whole-genome sequencing, posing a difficulty in giving adequate treatment and genetic counseling. The analysis of genomic data in rare disorders mostly considers the presence of single gene variants in coding regions that follow a concrete monogenic mode of inheritance. A digenic inheritance, with variants in two functionally-related genes in the same individual, is a plausible alternative that might explain the genetic basis of the disease in some cases. In this case, digenic disease combinations should be absent or underrepresented in healthy individuals. We develop a framework to evaluate the significance of digenic combinations and test its statistical power in different scenarios. We suggest that this approach will be relevant with the advent of new sequencing efforts including hundreds of thousands of samples., This study was funded by grants RTI2018-096824-B-C22 (FC), PID2021-125106OB-C32 (FC), RTI2018-096824-B-C21 (JIA) and PID2021-125106OB-C31 (JIA) funded by MCIN/ AEI /10.13039/501100011033/ and FEDER Una manera de hacer Europa; Direcció General de Recerca- Generalitat de Catalunya (2017SGR-702) (FC); and CERCA Programme/Generalitat de Catalunya (JIA). NMR was supported by grant 2021 FI_B_00296 from Agència de Gestió d’Ajuts Universitaris i de Recerca, Generalitat de Catalunya. This research was made possible through access to the data and findings generated by the 100,000 Genomes Project. The 100,000 Genomes Project is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The 100,000 Genomes Project is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK and the Medical Research Council have also funded research infrastructure. The 100,000 Genomes Project uses data provided by patients and collected by the National Health Service as part of their care and support.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Assessing the digenic model in rare disorders using population sequencing data

  • Moreno-Ruiz, Nerea
  • Lao, Oscar
  • Arostegui, Juan Ignacio
  • Laayouni, Hafid
  • Casals, Ferran
  • Genomics England Research Consortium
An important fraction of patients with rare disorders remains with no clear genetic diagnostic, even after whole-exome or whole-genome sequencing, posing a difficulty in giving adequate treatment and genetic counseling. The analysis of genomic data in rare disorders mostly considers the presence of single gene variants in coding regions that follow a concrete monogenic mode of inheritance. A digenic inheritance, with variants in two functionally-related genes in the same individual, is a plausible alternative that might explain the genetic basis of the disease in some cases. In this case, digenic disease combinations should be absent or underrepresented in healthy individuals. We develop a framework to evaluate the significance of digenic combinations and test its statistical power in different scenarios. We suggest that this approach will be relevant with the advent of new sequencing efforts including hundreds of thousands of samples., This study was funded by grants RTI2018-096824-B-C22 (FC), PID2021-125106OB-C32 (FC), RTI2018-096824-B-C21 (JIA) and PID2021-125106OB-C31 (JIA) funded by MCIN/ AEI /10.13039/501100011033/ and FEDER Una manera de hacer Europa; Direcció General de Recerca- Generalitat de Catalunya (2017SGR-702) (FC); and CERCA Programme/Generalitat de Catalunya (JIA). NMR was supported by grant 2021 FI_B_00296 from Agència de Gestió d’Ajuts Universitaris i de Recerca, Generalitat de Catalunya. This research was made possible through access to the data and findings generated by the 100,000 Genomes Project. The 100,000 Genomes Project is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The 100,000 Genomes Project is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK and the Medical Research Council have also funded research infrastructure. The 100,000 Genomes Project uses data provided by patients and collected by the National Health Service as part of their care and support., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Somatic genetic variation in healthy tissue and non-cancer diseases

  • Solís-Moruno, Manuel
  • Batlle-Masó, Laura
  • Bonet, Núria
  • Arostegui, Juan Ignacio
  • Casals, Ferran
© The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/., Somatic genetic variants have been studied for several years mostly concerning cancer, where they contribute to its origin and development. It is also clear that the somatic variants load is greater in aged individuals in comparison to younger ones, pointing to a cause/consequence of the senescence process. More recently, researchers have focused on the role of this type of variation in healthy tissue and its dynamics in cell lineages and different organs. In addition, somatic variants have been described to contribute to monogenic diseases, and the number of evidences of their role in complex disorders is also increasing. Thanks to recent advances in next-generation sequencing technologies, this type of genetic variation can be now more easily studied than in the past, although we still face some important limitations. Novel strategies for sampling, sequencing and filtering are being investigated to detect these variants, although validating them with an orthogonal approach will most likely still be needed. In this review, we aim to update our knowledge of somatic variation detection and its relation to healthy tissue and non-cancer diseases., This study was funded by grants PID2021-125106OB-C32 (FC), RTI2018-096824-B-C22 (FC), RTI2018-096824-B-C21 (JIA) and PID2021-125106OB-C31 (JIA) funded by MCIN/ AEI /10.13039/501100011033/ and FEDER Una manera de hacer Europa; Direcció General de Recerca- Generalitat de Catalunya (2017SGR-702) (FC); and CERCA Programme/Generalitat de Catalunya (JIA). MS-M was supported by the Ministerio de Economía y Competitividad, Spain (Maria de Maetzu grant MDM-2014-0370-16-3)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Excess of Carriers in Rare Disorders Suggests a Nonpathogenic Effect for Most Variants of Uncertain Significance

  • Medaglia, Stefano
  • Reig-Palou, Jaume
  • Bellés, Ariadna
  • Moreno-Ruiz, Nerea
  • Rodríguez, Jairo
  • Armengol, Xavier
  • Aróstegui, Juan Ignacio
  • Armengol, Lluís
  • Guillén, Juan José
  • Laayouni, Hafid
  • Casals, Ferran
Functional annotation and interpretation of genetic variants are a critical step in genetic diagnosis, as it may lead to personalized therapeutic options and genetic counseling. While the number of confirmed pathogenic genetic variants in an individual is relatively low, the number of variants of uncertain significance (VOUS) can be considerably higher, increasing the number of potential carriers of genetic disorders. Thus, reducing uncertainty and assessing the real effect of VOUS are crucial for clinical and medical genetics. In this study, we evaluated the efficacy of genetic screening technologies in accurately predicting pathogenic variants and their corresponding disease prevalence in a cohort of over 6000 healthy individuals involved in assisted reproduction programs. Using data from 305 genes associated with recessive disorders, we determined the frequency of carriers of pathogenic variants and VOUS in our dataset and compared the predicted prevalence based on this information with reported population prevalence data. The higher predicted prevalence in some disorders when considering VOUS suggests a mostly benign effect., This work was supported by grants RTI2018-096824-B-C22 (F.C.), PID2021-125106OB-C32 (F.C.), RTI2018-096824-B-C21(J.I.A.), and PID2021-125106OB-C31 (J.I.A.) funded by MCIN/AEI / 10.13039/501100011033/ and FEDER Una manera de hacer Europa; Agència de Gestió d'Ajuts Universitaris I de Recerca-Generalitat de Catalunya (2021SGR01093) (F.C.). N.M.-R. was supported by grant 2021 FI_B_00296 from Agència de Gestió d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genotype-phenotype correlations and putative modifier genes in SYNGAP1 Encephalopathy

  • Aranda, Selena
  • Ribeiro-Constante, Juliana
  • Tristán-Noguero, Alba
  • Moreno-Ruiz, Nerea
  • Arenas, Concepción
  • Martínez Calvo, Fernando Francisco
  • Ibáñez-Micó, Salvador
  • Peña Segura, José Luis
  • Ramos-Fernández, José Miguel
  • Moyano Chicano, María del Carmen
  • Camino León, Rafael
  • Soto-Insuga, Víctor
  • González-Alguacil, Elena
  • Valera Dávila, Carlos
  • Fernández-Jaén, Alberto
  • Plans, Laura
  • Camacho, Ana
  • Visa-Reñé, Nuria
  • Martín-Tamayo Blázquez, María del Pilar
  • Paredes-Carmona, Fernando
  • Marti-Carrera, Itxaso
  • Ginot-Julià, Guillem
  • Hernández-Fabián, Aránzazu
  • Tomàs Daví, Meritxell
  • Casadesús Sànchez, Mercè
  • Cuesta Herraiz, Laura
  • Fuentes Pita, Patricia
  • Bermejo González, Teresa
  • O'Callaghan, Mar
  • Iglesias Santa Polonia, Federico Felipe
  • Cazorla, María Rosario
  • Ferrando Lucas, María Teresa
  • González-Meneses, Antonio
  • Sala-Coromina, Júlia
  • Macaya, Alfons
  • Lasa-Aranzasti, Amaia
  • Cueto-González, Anna Mª
  • Párraga, Francisca Valera
  • Plana, Jaume Campistol
  • Serrano, Mercedes
  • Alonso, Xenia
  • Valenzuela Palafoll, Maria Irene
  • Monteagudo, Eines
  • Alonso-Colmenero, Itziar
  • Sans Capdevila, Oscar
  • Casals, Ferran
  • Cormand, Bru
  • García-Cazorla, Ángeles
  • Bayés, Àlex
  • Mitjans, Marina
Synaptic Ras GTPase-Activating Protein 1 (SynGAP) is a key regulator of synaptic plasticity, neurodevelopment, and neuronal circuit function. It is encoded by the SYNGAP1 gene, in which de novo dominant pathogenic variants are a major cause of SYNGAP1 Encephalopathy, a rare neurodevelopmental disorder characterised by intellectual disability, epilepsy, autistic traits, and other clinical manifestations. While some genetic studies have reported genotype-phenotype correlations in this condition, our understanding of how specific genetic variants contribute to the heterogeneous clinical symptoms remain limited. Here, we analysed a cohort of 44 cases extensively characterised at the phenotypic level to investigate the impact of genetic variants in SYNGAP1 and in potentially modulatory genes on the clinical features of SYNGAP1 Encephalopathy. Our results include the identification of four previously unreported likely pathogenic SYNGAP1 variants associated with the disease. In our cohort, individuals carrying variants within the PH domain of SynGAP exhibit milder phenotypes compared with other patients. Finally, patients harbouring rare or low-frequency variants in SYNGAP1-related genes tend to present with higher global severity. Taken together, these findings suggest that the location of SYNGAP1 variants, together with additional genetic modifiers, may contribute to variability in clinical presentation and disease severity. Further studies in larger cohorts and functional validation are needed to refine genotype-phenotype correlations and to support the development of personalized management strategies., The authors declare that financial support was received for the research, authorship, and/or publication of this article. AG-C is supported by FI21/0073 and FI24/00469 “Instituto de Salud Carlos III (ISCIII)” and “Fondo Europeo de desarrollo regional (FEDER)”. AT-N was supported by a “Margarita Salas” contract from Next-Generation Europe and postdoc mobility grants “EMBO short exchange research” grant and “José Castillejo” grant. AB financial support was provided by: PID2024-160538OB-I00, PID 2021-124411OB-I00 and RTI 2018–097037-B-I00 (MINECO/MCI/AEI/FEDER, EU), Award AC17/00005 by ISCIII through AES2017 and within the NEURON framework, Ramón y Cajal Fellowship (RYC-2011-08391p), IEDI-2017-00822 and AGAUR (2017 SGR 1776 and 2021 SGR 01005). AB and AT-N thank the CERCA Programme/Generalitat de Catalunya for institutional support. NM-R was supported by grant 2021 FI_B_00296 from Agència de Gestió d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya. AC-G is member of the European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA, funded by the European Union, under the grant agreement N°101156387. The study was supported by the generous funding provided by the association of Spanish SYNGAP1-DEE families, SYNGAP1 España. AB and BC wish to thank support from the Spanish Red de Investigación RED2024–154082-T., Funding supporting this study was provided by the Spanish ‘Ministerio de Ciencia, Innovación y Universidades’, funded by MICIU/AEI/10.13039/501100011033/ and FEDER-EU (PID2021-1277760B-I00 and PID2024-158634OB-I00, to BC; PID2022-139740OA-I00 to MMi; PID2021-125106OB-C32 and PID2024-161190OB-C22 to FC), ‘Generalitat de Catalunya/AGAUR’ (2021-SGR-01093, to BC and MMi), ICREA Academia 2021 (to BC), and ‘Fundació La Marató de TV3′ (202218-31, to BC). This article is part of the grant RYC2021-033573-I funded by MCIN/AEI/10.13039/501100011033 and by the European Union “NextGenerationEU/PRTR”. SA is supported by a Juan de la Cierva fellowship from the Spanish Ministry of Science and Innovation (JDC2024-055161-I)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Somatic genetic variation in healthy tissue and non-cancer diseases

  • Solís Moruno, Manuel, 1993-
  • Batlle Masó, Laura, 1993-
  • Bonet, Núria
  • Aróstegui Gorospe, Juan Ignacio
  • Casals López, Ferran
Somatic genetic variants have been studied for several years mostly concerning cancer, where they contribute to its origin and development. It is also clear that the somatic variants load is greater in aged individuals in comparison to younger ones, pointing to a cause/consequence of the senescence process. More recently, researchers have focused on the role of this type of variation in healthy tissue and its dynamics in cell lineages and different organs. In addition, somatic variants have been described to contribute to monogenic diseases, and the number of evidences of their role in complex disorders is also increasing. Thanks to recent advances in next-generation sequencing technologies, this type of genetic variation can be now more easily studied than in the past, although we still face some important limitations. Novel strategies for sampling, sequencing and filtering are being investigated to detect these variants, although validating them with an orthogonal approach will most likely still be needed. In this review, we aim to update our knowledge of somatic variation detection and its relation to healthy tissue and non-cancer diseases., This study was funded by grants PID2021-125106OB-C32 (FC), RTI2018-096824-B-C22 (FC), RTI2018-096824-B-C21 (JIA) and PID2021-125106OB-C31 (JIA) funded by MCIN/ AEI /10.13039/501100011033/ and FEDER Una manera de hacer Europa; Direcció General de Recerca- Generalitat de Catalunya (2017SGR-702) (FC); and CERCA Programme/Generalitat de Catalunya (JIA). MS-M was supported by the Ministerio de Economía y Competitividad, Spain (Maria de Maetzu grant MDM-2014-0370-16-3).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism

  • Mascaró, Jose Manuel
  • Tejedor Vaquero, Sonia, 1988-
  • Magri, Giuliana, 1978-
  • Bonet, Núria
  • Solís Moruno, Manuel, 1993-
  • Cerutti, Andrea, 1965-
  • Fornas Carreño, Oscar
  • Aróstegui Gorospe, Juan Ignacio
Background: The vacuoles, E1-enzyme, X linked, autoinflammatory and somatic (VEXAS) syndrome is an adult-onset autoinflammatory disease (AID) due to postzygotic UBA1 variants. Objectives: To investigate the presence of VEXAS syndrome among patients with adult-onset undiagnosed AID. Additional studies evaluated the mosaicism distribution and the circulating cytokines. Methods: Gene analyses were performed by both Sanger and amplicon-based deep sequencing. Patients' data were collected from their medical charts. Cytokines were quantified by Luminex. Results: Genetic analyses of enrolled patients (n=42) identified 30 patients carrying UBA1 pathogenic variants, with frequencies compatible for postzygotic variants. All patients were male individuals who presented with a late-onset disease (mean 67.5 years; median 67.0 years) characterised by cutaneous lesions (90%), fever (66.7%), pulmonary manifestations (66.7%) and arthritis (53.3%). Macrocytic anaemia and increased erythrocyte sedimentation rate and ferritin were the most relevant analytical abnormalities. Glucocorticoids ameliorated the inflammatory manifestations, but most patients became glucocorticoid-dependent. Positive responses were obtained when targeting the haematopoietic component of the disease with either decitabine or allogeneic haematopoietic stem cell transplantation. Additional analyses detected the UBA1 variants in both haematopoietic and non-haematopoietic tissues. Finally, analysis of circulating cytokines did not identify inflammatory mediators of the disease. Conclusion: Thirty patients with adult-onset AID were definitively diagnosed with VEXAS syndrome through genetic analyses. Despite minor interindividual differences, their main characteristics were in concordance with previous reports. We detected for the first time the UBA1 mosaicism in non-haematopoietic tissue, which questions the previous concept of myeloid-restricted mosaicism and may have conceptual consequences for the disease mechanisms., This work has been partially funded by RTI2018-096824-B-C21 (JIA) and RTI2018-096824-B-C22 (FC) grant from the Spanish Ministry of Science, Innovation and Universities co-funded by Agencia Estatal de Investigación/European Regional Development Fund una manera de hacer Europa. PID2021-125106OB-C31 (JIA) and PID2021-125106OB-C32 (FC) grants from the Ministerio de Ciencia e Innovación (MCIN) | Agencia Estatal de Investigación (AEI) | 10.13039/501100011033 | Fondo Europeo de Desarrollo Regional (FEDER), UE.PI19/01567 grant from Instituto de Salud Carlos III (ISCIII) co-funded by the European Union (AM-V).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Novel insights into the clinical features, genetic spectrum and clonal evolution of patients carrying NLRP3 mosaicism

  • Bonet, Núria
  • Pesqué, David
  • Giménez Arnau, Anna Maria
  • Laayouni, Hafid, 1968-
  • Fornas Carreño, Oscar
  • Aróstegui Gorospe, Juan Ignacio
NLRP3 mosaicism is a well-established mechanism causing the monogenic autoinflammatory disease named cryopyrin-associated periodic syndromes (CAPS). The number of reported patients with NLRP3 mosaicism is small, and the knowledge about the long-term disease behavior is limited. Herein we assembled the largest cohort of individuals with NLRP3 mosaicism reported to date to obtain additional evidence that strengthens the understanding of this disease. The novel genetic data were obtained by using Sanger and next-generation sequencing methods, whereas in vitro analyses determined the functional consequences of detected variants. A total of seventeen individuals with NLRP3 mosaicism were enrolled, with 16/17 experiencing different CAPS phenotypes. An overrepresentation of late-onset forms was detected (37.5%). Overall, clinical manifestations, analytical results, and outcomes of treatments were markedly similar to those detected in patients with germline variants. A large mutational diversity was identified, with 16 different variants among 17 individuals. Two main patterns of mosaicism (extended vs. myeloid-restricted) were detected, with the last one overrepresented in the late-onset group. The evaluation of mosaicism over time identified three different patterns, being the group with stable mosaicism the largest one. Collected evidence supports the marked similarities among patients carrying somatic or germline NLRP3 variants. The overrepresentation of NLRP3 mosaicism in late-onset forms should be considered in patients with inflammatory manifestations starting in adulthood. Analysis of mosaicism at the biological level confirms the two known patterns of corporal distribution and reveals that mosaicism remains stable over time in most patients, but it may also vary during the course of the disease., This work has been partially funded by: • PID2021-125106OB-C31 (JIA), PID2020-116709RB-I00 (PP), CNS2022-135101 (PP), PID2023-147531OB-I00 (PP), PID2021-125106OB-C32 (FC), RED2022-134511-T (PP, JIA) and PID2021-125106OB-C33 (OF) grants from the Ministerio de Ciencia e Innovación (MCIN) | Agencia Estatal de Investigación (AEI) | https://doi.org/10.13039/501100011033 | Fondo Europeo de Desarrollo Regional (FEDER), UE | European Union «Next Generation EU/PRTR». • AC21_2/00042 (JIA) and IFI22/00031 (JG-V) grants from the Instituto de Salud Carlos III co-funded by Unión Europea Next Generation EU | Mecanismo para la Recuperación y la Resiliencia (MRR) | Plan de Recuperación, Transformación y Resiliencia (PRTR). • 2021SGR01093 | Agència de Gestió d’Ajuts Universitaris i de Recerca | Generalitat de Catalunya (FC). • 21897/PI/22 (PP) and 21214/FPI/19 (LH-N) | Fundación Séneca, Región de Murcia, Spain.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Assessing the digenic model in rare disorders using population sequencing data

  • Moreno-Ruiz, Nerea
  • Genomics England Research Consortium
  • Lao Grueso, Oscar, 1976-
  • Aróstegui Gorospe, Juan Ignacio
  • Laayouni, Hafid, 1968-
  • Casals López, Ferran
An important fraction of patients with rare disorders remains with no clear genetic diagnostic, even after whole-exome or whole-genome sequencing, posing a difficulty in giving adequate treatment and genetic counseling. The analysis of genomic data in rare disorders mostly considers the presence of single gene variants in coding regions that follow a concrete monogenic mode of inheritance. A digenic inheritance, with variants in two functionally-related genes in the same individual, is a plausible alternative that might explain the genetic basis of the disease in some cases. In this case, digenic disease combinations should be absent or underrepresented in healthy individuals. We develop a framework to evaluate the significance of digenic combinations and test its statistical power in different scenarios. We suggest that this approach will be relevant with the advent of new sequencing efforts including hundreds of thousands of samples., This study was funded by grants RTI2018-096824-B-C22 (FC), PID2021-125106OB-C32 (FC), RTI2018-096824-B-C21 (JIA) and PID2021-125106OB-C31 (JIA) funded by MCIN/ AEI /10.13039/501100011033/ and FEDER Una manera de hacer Europa; Direcció General de Recerca- Generalitat de Catalunya (2017SGR-702) (FC); and CERCA Programme/Generalitat de Catalunya (JIA). NMR was supported by grant 2021 FI_B_00296 from Agència de Gestió d’Ajuts Universitaris i de Recerca, Generalitat de Catalunya. This research was made possible through access to the data and findings generated by the 100,000 Genomes Project. The 100,000 Genomes Project is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The 100,000 Genomes Project is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK and the Medical Research Council have also funded research infrastructure. The 100,000 Genomes Project uses data provided by patients and collected by the National Health Service as part of their care and support.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Somatic genetic variation in healthy tissue and non-cancer diseases

  • Solís-Moruno, Manuel|||0000-0001-7407-8896
  • Batlle-Masó, Laura|||0000-0002-4209-176X
  • Bonet, Núria|||0000-0003-0574-2575
  • Aróstegui, Juan Ignacio|||0000-0003-4757-504X
  • Casals, Ferran|||0000-0002-8941-0369
Somatic genetic variants have been studied for several years mostly concerning cancer, where they contribute to its origin and development. It is also clear that the somatic variants load is greater in aged individuals in comparison to younger ones, pointing to a cause/consequence of the senescence process. More recently, researchers have focused on the role of this type of variation in healthy tissue and its dynamics in cell lineages and different organs. In addition, somatic variants have been described to contribute to monogenic diseases, and the number of evidences of their role in complex disorders is also increasing. Thanks to recent advances in next-generation sequencing technologies, this type of genetic variation can be now more easily studied than in the past, although we still face some important limitations. Novel strategies for sampling, sequencing and filtering are being investigated to detect these variants, although validating them with an orthogonal approach will most likely still be needed. In this review, we aim to update our knowledge of somatic variation detection and its relation to healthy tissue and non-cancer diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice

  • Calls, Aina|||0000-0002-8233-456X
  • Torres Espín, Abel|||0000-0002-9787-8738
  • Tormo, Marc
  • Martínez-Escardó, Laura|||0000-0003-2979-4804
  • Bonet, Núria|||0000-0003-0574-2575
  • Casals, Ferran|||0000-0002-8941-0369
  • Navarro, X. (Xavier)|||0000-0001-9849-902X
  • Yuste, Victor José|||0000-0001-5322-9261
  • Udina i Bonet, Esther|||0000-0003-1954-8562
  • Bruna, Jordi|||0000-0001-6895-5047
Peripheral neuropathy is a relevant dose-limiting adverse event that can affect up to 90% of oncologic patients with colorectal cancer receiving oxaliplatin treatment. The severity of neurotoxicity often leads to dose reduction or even premature cessation of chemotherapy. Unfortunately, the limited knowledge about the molecular mechanisms related to oxaliplatin neurotoxicity leads to a lack of effective treatments to prevent the development of this clinical condition. In this context, the present work aimed to determine the exact molecular mechanisms involved in the development of oxaliplatin neurotoxicity in a murine model to try to find new therapeutical targets. By single-cell RNA sequencing (scRNA-seq), we studied the transcriptomic profile of sensory neurons and satellite glial cells (SGC) of the Dorsal Root Ganglia (DRG) from a well-characterized mouse model of oxaliplatin neurotoxicity. Analysis of scRNA-seq data pointed to modulation of inflammatory processes in response to oxaliplatin treatment. In this line, we observed increased levels of NF-kB p65 protein, pro-inflammatory cytokines, and immune cell infiltration in DRGs and peripheral nerves of oxaliplatin-treated mice, which was accompanied by mechanical allodynia and decrease in sensory nerve amplitudes. Our data show that, in addition to the well-described DNA damage, oxaliplatin neurotoxicity is related to an exacerbated pro-inflammatory response in DRG and peripheral nerves, and open new insights in the development of anti-inflammatory strategies as a treatment for preventing peripheral neuropathy induced by oxaliplatin.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Spanish cohort of VEXAS syndrome, clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism

  • Mascaro, Jose Manuel|||0000-0001-9327-2555
  • Rodriguez-Pinto, Ignasi
  • Poza, Gabriela
  • Mensa-Vilaro, Anna|||0000-0001-7541-9672
  • Fernández-Martín, Julián|||0000-0002-9391-4316
  • Caminal-Montero, Luis|||0000-0002-4044-8235
  • Espinosa, Gerard|||0000-0003-1336-0163
  • Hernández Rodríguez, José|||0000-0002-2357-2015
  • Diaz, Marina
  • Rita-Marques, Joana
  • Sanmartí, Raimon|||0000-0002-8864-3806
  • Castañeda, Santos|||0000-0002-7748-853X
  • Colunga, Dolores
  • Coto-Hernández, Rubén
  • Fanlo, Patricia
  • Elejalde, Jose Ignacio
  • Segundo, Bujan
  • Figueras, Ignasi
  • Marco, Francisco Manuel
  • Andrés, Mariano|||0000-0002-0219-9055
  • Suárez Díaz, Silvia|||0000-0002-8558-5452
  • Gonzalez-Garcia, Andres
  • Fustà-Novell, Xavier|||0000-0001-6631-6030
  • Garcia-Belando, Clara
  • Granados-Maturano, Ana|||0000-0002-5323-5909
  • Fernández-Figueras, Maria Teresa|||0000-0002-2366-7110
  • Quilis, Neus|||0000-0001-7509-7212
  • Orriols-Caba, Maria
  • Gómez de la Torre, Ricardo
  • Cid, María Cinta|||0000-0002-4730-0938
  • Espígol Frigolé, Georgina|||0000-0002-8299-0209
  • Alvarez-Abella, Alba
  • Labrador, Eztizen
  • Rozman, Maria|||0000-0002-2641-1110
  • López Guerra, Mónica|||0000-0002-5545-0178
  • Castillo, Paola|||0000-0002-9284-8601
  • Álamo, José Ramón
  • González Roca, Eva|||0000-0002-1126-0321
  • Plaza, Susana
  • Fabregat, Virginia
  • Lara, Rocio
  • Vicente-Rabaneda, Esther F.
  • Tejedor Vaquero, Sonia|||0000-0003-2873-4981
  • Magri, Giuliana|||0000-0002-0163-3542
  • Bonet, Nuria
  • Solis-Moruno, Manuel
  • Cerutti, Andrea|||0000-0003-3026-4704
  • Fornas, Òscar|||0000-0003-2017-9100
  • Casals, Ferran|||0000-0002-8941-0369
  • Yagüe, Jordi|||0000-0001-8210-1929
  • Aróstegui, Juan Ignacio|||0000-0003-4757-504X
The vacuoles, E1-enzyme, X linked, autoinflammatory and somatic (VEXAS) syndrome is an adult-onset autoinflammatory disease (AID) due to postzygotic UBA1 variants. To investigate the presence of VEXAS syndrome among patients with adult-onset undiagnosed AID. Additional studies evaluated the mosaicism distribution and the circulating cytokines. Gene analyses were performed by both Sanger and amplicon-based deep sequencing. Patients' data were collected from their medical charts. Cytokines were quantified by Luminex. Genetic analyses of enrolled patients (n=42) identified 30 patients carrying UBA1 pathogenic variants, with frequencies compatible for postzygotic variants. All patients were male individuals who presented with a late-onset disease (mean 67.5 years; median 67.0 years) characterised by cutaneous lesions (90%), fever (66.7%), pulmonary manifestations (66.7%) and arthritis (53.3%). Macrocytic anaemia and increased erythrocyte sedimentation rate and ferritin were the most relevant analytical abnormalities. Glucocorticoids ameliorated the inflammatory manifestations, but most patients became glucocorticoid-dependent. Positive responses were obtained when targeting the haematopoietic component of the disease with either decitabine or allogeneic haematopoietic stem cell transplantation. Additional analyses detected the UBA1 variants in both haematopoietic and non-haematopoietic tissues. Finally, analysis of circulating cytokines did not identify inflammatory mediators of the disease. Thirty patients with adult-onset AID were definitively diagnosed with VEXAS syndrome through genetic analyses. Despite minor interindividual differences, their main characteristics were in concordance with previous reports. We detected for the first time the UBA1 mosaicism in non-haematopoietic tissue, which questions the previous concept of myeloid-restricted mosaicism and may have conceptual consequences for the disease mechanisms.